Exxon Mobil Files Restated Certificate of Incorporation
Exxon Mobil has restated its Certificate of Incorporation in preparation for a July 1, 2026, effective date, incorporating updates to director liability clauses. This administrativ…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Exxon Mobil has restated its Certificate of Incorporation in preparation for a July 1, 2026, effective date, incorporating updates to director liability clauses. This administrativ…
Greenpro Capital Corp has submitted EX-10.1 to the SEC. The snippet provided contains file headers but does not include the specific terms or details of the exhibit.
Flutter Entertainment confirms 173,481,132 ordinary shares in issue as of June 30, 2026. This figure serves as the denominator for reporting obligations under UK transparency rules…
Independent accountant CBIZ issues a letter confirming statements in the company's recent 8-K filing. This disclosure supports regulatory compliance and statement accuracy.
Metallus Inc. has entered into a new Fifth Amended and Restated Credit Agreement with various lenders. This update to the company's asset-based lending facility is disclosed in the…
Patriot National Bancorp announced the termination of its formal agreement with the OCC effective June 30, 2026. This resolution is expected to reduce regulatory oversight and asso…
InnSuites Hospitality Trust received a NYSE American notice for non-compliance with continued listing standards due to equity deficits and losses, pledging a plan by July 24 to reg…
The FDA has approved TREGZI, the first regulatory T cell-based immunotherapy, to improve chronic GVHD-free survival in adult blood cancer patients undergoing stem cell transplant.
The Federal Home Loan Bank of New York filed Exhibit 99.1, Schedule A, listing fixed-rate and floating-rate obligations totaling over $1.5 billion with maturities ranging from 2026…
McEwen Inc. is set to join the Russell 2000 Index on June 29, 2026. This inclusion boosts visibility for index-tracking strategies managing over $12 trillion in assets.
Catalyst Pharmaceuticals reported top-line Phase 1 data for vamorolone demonstrating balanced corticosteroid activity without evidence of immunosuppression. This validates the drug…
Verizon ABS II LLC retained Morgan Lewis and Morris James as legal counsel for a Form SF-3 registration statement. This filing signals the company is advancing regulatory and poten…
MasterCraft Boat Holdings filed its Fifth Amended and Restated Bylaws to establish updated corporate governance rules. This routine regulatory update outlines meeting procedures an…
The Federal Reserve and other agencies released a list identifying nonmetropolitan middle-income geographies that are distressed or underserved. This action aims to support access …
The company regained compliance with Nasdaq's bid price rule after completing a mandatory one-for-six reverse stock split. This reinstatement is subject to a monitoring period thro…
Moleculin Biotech has filed an exhibit with the SEC, usually containing supplementary information such as a press release. Investors should review this document for specific corpor…
USRC and Akebia halted the VOICE trial due to improved safety outcomes with Vafseo compared to ESAs. The interim data indicates a significant reduction in hospitalizations, support…
Vivani Medical Inc. filed an amended and restated 2022 omnibus incentive plan to authorize grants of stock awards to officers and directors. This governance update ensures the comp…
Monopar Therapeutics received Rare Pediatric Disease designation for ALXN1840 treating Wilson disease. This grants potential eligibility for a Pediatric Priority Review Voucher upo…
Novocure's Optune Pax device received a CE Mark for locally advanced pancreatic cancer supported by significant overall survival improvements in the PANOVA-3 trial. This regulatory…